Proposed Data Collection Submitted for Public Comment and Recommendations, 13391-13393 [2021-04670]
Download as PDF
<![CDATA[
13391
Federal Register / Vol. 86, No. 43 / Monday, March 8, 2021 / Notices
operators with information to notify and
contact individuals and further
investigate this exposure by contacting
others who may have been potentially
exposed to disease. However, there
currently is no standardized tool or form
to collect pertinent information
regarding the outcome of such
investigations. To address the need to
inform CDC of additional actions that
may be needed to further protect public
health based on the outcome of the
contact investigations, CDC has
developed forms to assist health
departments and maritime conveyance
operators in reporting back to CDC. The
forms are specific to the nature of the
investigation; Tuberculosis (TB),
Measles, and Rubella, or the General
form to for other diseases of public
health concern. The purpose of the
forms is the same: to collect information
to help CDC quarantine officials to fully
understand the extent of disease spread
and transmission during travel and to
inform the development and or
refinement of investigative protocols,
aimed at reducing the spread of
communicable disease.
Respondents are state and local health
departments and maritime conveyance
operators. Respondents may use these
standardized forms to submit data
voluntarily to CDC for each individual
contacted via a secure means of their
choice, (e.g., web-based application, fax
or email). Additional respondents are
Cruise Ship Medical Staff/Cargo Ship
Managers and State/local health
department staff. There is no cost to
respondents other than their time to
complete the form and submit the data
to CDC.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Cruise Ship Physicians/Cargo Ship
Managers.
Clinically Active TB Contact Investigation
Outcome
Reporting
Form—Maritime.
Varicella Investigation Outcome Reporting Form.
Influenza Like Illness Investigation
Outcome Reporting Form.
General Contact Investigation Outcome Reporting Form—Air.
TB Contact Investigation Outcome
Reporting Form—Air.
Measles Contact Investigation Outcome Reporting Form—Air.
Rubella Contact Investigation Outcome Reporting Form—Air.
General Contact Investigation Outcome Reporting Form—Land.
Cruise Ship Physicians/Cargo Ship
Managers.
Cruise Ship Physicians/Cargo Ship
Managers.
State/Local public health staff ...........
State/Local public health staff ...........
State/Local public health staff ...........
State/Local public health staff ...........
State/Local public health staff ...........
Total ...........................................
...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–04673 Filed 3–5–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–21–21DJ Docket No. CDC–2021–
0020]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondent
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
SUMMARY:
VerDate Sep<11>2014
19:05 Mar 05, 2021
Jkt 253001
20/60
5
29
1
20/60
10
45
1
20/60
15
36,000
1
5/60
3,000
100
1
5/60
8
189
1
5/60
16
38
1
5/60
3
15
1
5/60
1
........................
........................
........................
3,058
CDC must receive written
comments on or before May 7, 2021.
You may submit comments,
identified by Docket No. CDC–2021–
0020 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
ADDRESSES:
Fmt 4703
Total burden
hours
1
DATES:
Frm 00113
Average
burden per
response
15
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘American Academy of Pediatrics
(AAP) Resident Training Program on
Children with Fetal Alcohol Spectrum
Disorders (FASD)’’. This project will
collect data to evaluate the efficacy of a
newly developed pediatric resident
training curriculum regarding
identification, referral and care of
children with fetal alcohol spectrum
disorders (FASD) and their families.
PO 00000
Number of
responses per
respondent
Sfmt 4703
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
E:\FR\FM\08MRN1.SGM
08MRN1
13392
Federal Register / Vol. 86, No. 43 / Monday, March 8, 2021 / Notices
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
American Academy of Pediatrics
(AAP) Resident Training on Children
with Fetal Alcohol Spectrum Disorders
(FASD)—New—National Center on
Birth Defects and Developmental
Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Prenatal exposure to alcohol and
other teratogens can have serious
neurodevelopmental impact including
Fetal Alcohol Spectrum Disorders
(FASD). FASD is an umbrella term that
encompasses several, more specific,
diagnoses. These conditions are
associated with lifelong physical and
neurodevelopmental abnormalities,
including growth problems and prenatal
brain damage. This brain damage may
lead to developmental, behavioral and
neurocognitive impairments. Infants
with a FASD are rarely recognized at
birth by hospital staff. Further, at later
ages, these children may be overlooked
or misdiagnosed. While there is no cure
for FASDs, early identification and
intervention can mitigate adverse
effects.
In Bright Futures, the American
Academy of Pediatrics (AAP) suggest
routinely obtaining prenatal alcohol
exposure history for all pediatric
patients. The AAP also recommends
developmental monitoring and
screening for all patients for behavioral
and neurodevelopmental issues.
Pediatricians are critical in the process
of early identification, referral and
ongoing care of children with FASDs.
Through regular well-child
appointments, addressing parental
concerns, and managing a family’s
pediatric medical home, pediatricians
are in a key position to obtain (and
document) prenatal exposure history to
alcohol and other drugs. Relatedly, their
role in monitoring development enables
them to identify issues early that in turn
facilitates timely treatment, especially
early intervention. It is important for
pediatricians to learn these skills early
in their clinical training to make them
routine throughout their clinical
practice careers.
To facilitate and strengthen
pediatricians’ role, with CDC funding,
the American Academy of Pediatrics
(AAP) has developed a curriculum and
program to provide first year pediatric
resident trainees with strategies, tools
and resources necessary for; (1)
obtaining prenatal history of exposure to
alcohol and other drugs for all their
patients, (2) recognizing clinical
manifestation of FASD in pediatric
primary care settings to expedite
diagnostic evaluation referrals, and (3)
caring for affected children and their
families in the pediatric medical home.
This program builds upon a pilot effort
that was approved under GenIC
Clearance for CDC/ATSDR Formative
Research and Tool Development title:
American Academy of Pediatrics
Resident Training in Developmental
Continuity Clinics with OMB Control
Number 0920–1154.
The curriculum is presented in two
phases. Phase One is a one-day, inperson, train-the-trainers session for
attending physicians who oversee
medical resident training in pediatrics.
Training will be provided by experts in
identification, diagnosis and care of
children with FASD. For Phase Two, the
trainer attending physicians will
implement a curriculum of continuing
medical education activities with their
first year pediatric residents. The
curriculum contains both required and
option activities that residents complete
with support and facilitation from
attending physicians. Evaluations are
conducted only for required activities. It
is estimated that 10 clinics will
participate in the project which could
include up to 10 attending physicians
and an average of 25 pediatric residents
per clinic (∼260 respondents/year).
Participant clinics are selected by a brief
application to the AAP. All
participation is voluntary. CDC requests
approval for an estimated 32 annual
burden hours. There is no cost to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Pediatricians ..................
Attending physicians Screening & Diagnosis
Pretest.
Attending physicians Screening & Diagnosis
Posttest.
Attending physicians Treatment Across Lifespan
Pretest.
Attending physicians Treatment Across Lifespan
Posttest.
Attending physicians Overcoming Social Attitudes Pretest.
Attending physicians Overcoming Social Attitudes Posttest.
Pediatricians ..................
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
Pediatricians ..................
Pediatricians ..................
Pediatricians ..................
Pediatricians ..................
VerDate Sep<11>2014
19:05 Mar 05, 2021
Jkt 253001
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
Burden per
response
(hours)
Number of
responses
Burden in
hours
10
1
10/60
2
10
1
10/60
2
10
1
10/60
2
10
1
10/60
2
10
1
10/60
2
10
1
10/60
2
E:\FR\FM\08MRN1.SGM
08MRN1
13393
Federal Register / Vol. 86, No. 43 / Monday, March 8, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Pediatricians ..................
Pediatricians ..................
Pediatricians ..................
Attending physicians Educational Care Pretest ..
Attending physicians Educational Care Posttest
Attending physicians Training Program Evaluation.
Resident Overall Effects & Prevalence Video
Pretest.
Resident Overall Effects & Prevalence Video
Posttest.
Resident Overall Program Evaluation .................
Attending physicians Overall Program Evaluation.
Pediatricians ..................
Pediatricians ..................
Pediatricians ..................
Pediatricians ..................
Total ........................
..............................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–04670 Filed 3–5–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–21–21DI; Docket No. CDC–2021–
0018]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CryptoNet Case Report Form. The
CryptoNet Case Report Form will be
used by federal, state, and local public
health officials responsible for
conducting interviews with reported
cases of cryptosporidiosis in their
jurisdiction in order to systematically
assess core exposure elements and risk
factors among cases of
cryptosporidiosis.
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
CDC must receive written
comments on or before May 7, 2021.
DATES:
VerDate Sep<11>2014
19:05 Mar 05, 2021
Jkt 253001
PO 00000
Frm 00115
Fmt 4703
Sfmt 4703
Burden in
hours
10
10
10
1
1
1
10/60
10/60
15/60
2
2
3
25
1
15/60
3
25
1
15/60
3
25
10
1
1
15/60
20/60
3
4
175
........................
........................
32
You may submit comments,
identified by Docket No. CDC–2021–
0018 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
ADDRESSES:
Burden per
response
(hours)
Number of
responses
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
CryptoNet Case Report Form—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Waterborne Disease Prevention
Branch (WDPB) in the Division of
Foodborne, Waterborne, and
Environmental Diseases (DFWED) works
to prevent domestic and global water,
sanitation, and hygiene (WASH) related
disease. The WDPB is comprised of four
teams, including the Domestic WASH
Epidemiology Team, which focuses on
the prevention and control of
waterborne and WASH-related disease
and outbreaks in the United States. One
of the diseases included in the team’s
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 86, Number 43 (Monday, March 8, 2021)]
[Notices]
[Pages 13391-13393]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04670]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-21-21DJ Docket No. CDC-2021-0020]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``American Academy of Pediatrics
(AAP) Resident Training Program on Children with Fetal Alcohol Spectrum
Disorders (FASD)''. This project will collect data to evaluate the
efficacy of a newly developed pediatric resident training curriculum
regarding identification, referral and care of children with fetal
alcohol spectrum disorders (FASD) and their families.
DATES: CDC must receive written comments on or before May 7, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0020 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies
[[Page 13392]]
must obtain approval from the Office of Management and Budget (OMB) for
each collection of information they conduct or sponsor. In addition,
the PRA also requires Federal agencies to provide a 60-day notice in
the Federal Register concerning each proposed collection of
information, including each new proposed collection, each proposed
extension of existing collection of information, and each reinstatement
of previously approved information collection before submitting the
collection to the OMB for approval. To comply with this requirement, we
are publishing this notice of a proposed data collection as described
below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
American Academy of Pediatrics (AAP) Resident Training on Children
with Fetal Alcohol Spectrum Disorders (FASD)--New--National Center on
Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Prenatal exposure to alcohol and other teratogens can have serious
neurodevelopmental impact including Fetal Alcohol Spectrum Disorders
(FASD). FASD is an umbrella term that encompasses several, more
specific, diagnoses. These conditions are associated with lifelong
physical and neurodevelopmental abnormalities, including growth
problems and prenatal brain damage. This brain damage may lead to
developmental, behavioral and neurocognitive impairments. Infants with
a FASD are rarely recognized at birth by hospital staff. Further, at
later ages, these children may be overlooked or misdiagnosed. While
there is no cure for FASDs, early identification and intervention can
mitigate adverse effects.
In Bright Futures, the American Academy of Pediatrics (AAP) suggest
routinely obtaining prenatal alcohol exposure history for all pediatric
patients. The AAP also recommends developmental monitoring and
screening for all patients for behavioral and neurodevelopmental
issues. Pediatricians are critical in the process of early
identification, referral and ongoing care of children with FASDs.
Through regular well-child appointments, addressing parental concerns,
and managing a family's pediatric medical home, pediatricians are in a
key position to obtain (and document) prenatal exposure history to
alcohol and other drugs. Relatedly, their role in monitoring
development enables them to identify issues early that in turn
facilitates timely treatment, especially early intervention. It is
important for pediatricians to learn these skills early in their
clinical training to make them routine throughout their clinical
practice careers.
To facilitate and strengthen pediatricians' role, with CDC funding,
the American Academy of Pediatrics (AAP) has developed a curriculum and
program to provide first year pediatric resident trainees with
strategies, tools and resources necessary for; (1) obtaining prenatal
history of exposure to alcohol and other drugs for all their patients,
(2) recognizing clinical manifestation of FASD in pediatric primary
care settings to expedite diagnostic evaluation referrals, and (3)
caring for affected children and their families in the pediatric
medical home. This program builds upon a pilot effort that was approved
under GenIC Clearance for CDC/ATSDR Formative Research and Tool
Development title: American Academy of Pediatrics Resident Training in
Developmental Continuity Clinics with OMB Control Number 0920-1154.
The curriculum is presented in two phases. Phase One is a one-day,
in-person, train-the-trainers session for attending physicians who
oversee medical resident training in pediatrics. Training will be
provided by experts in identification, diagnosis and care of children
with FASD. For Phase Two, the trainer attending physicians will
implement a curriculum of continuing medical education activities with
their first year pediatric residents. The curriculum contains both
required and option activities that residents complete with support and
facilitation from attending physicians. Evaluations are conducted only
for required activities. It is estimated that 10 clinics will
participate in the project which could include up to 10 attending
physicians and an average of 25 pediatric residents per clinic (~260
respondents/year). Participant clinics are selected by a brief
application to the AAP. All participation is voluntary. CDC requests
approval for an estimated 32 annual burden hours. There is no cost to
respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Burden per
Type of respondents Form name Number of Number of response Burden in
respondents responses (hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pediatricians.................................. Attending physicians Screening & 10 1 10/60 2
Diagnosis Pretest.
Pediatricians.................................. Attending physicians Screening & 10 1 10/60 2
Diagnosis Posttest.
Pediatricians.................................. Attending physicians Treatment Across 10 1 10/60 2
Lifespan Pretest.
Pediatricians.................................. Attending physicians Treatment Across 10 1 10/60 2
Lifespan Posttest.
Pediatricians.................................. Attending physicians Overcoming Social 10 1 10/60 2
Attitudes Pretest.
Pediatricians.................................. Attending physicians Overcoming Social 10 1 10/60 2
Attitudes Posttest.
[[Page 13393]]
Pediatricians.................................. Attending physicians Educational Care 10 1 10/60 2
Pretest.
Pediatricians.................................. Attending physicians Educational Care 10 1 10/60 2
Posttest.
Pediatricians.................................. Attending physicians Training Program 10 1 15/60 3
Evaluation.
Pediatricians.................................. Resident Overall Effects & Prevalence 25 1 15/60 3
Video Pretest.
Pediatricians.................................. Resident Overall Effects & Prevalence 25 1 15/60 3
Video Posttest.
Pediatricians.................................. Resident Overall Program Evaluation.... 25 1 15/60 3
Pediatricians.................................. Attending physicians Overall Program 10 1 20/60 4
Evaluation.
---------------------------------------------------------------
Total...................................... ....................................... 175 .............. .............. 32
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-04670 Filed 3-5-21; 8:45 am]
BILLING CODE 4163-18-P
